Walvax Biotechnology
SZSE:300142
¥ 12,06
+ ¥0,44 (3,79%)
12,06 ¥
+¥0,44 (3,79%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,00
Earnings Per Share
¥1,76
Revenue Per Share
73,76%
Gross Margin %
¥19,29 B
Market Cap
¥0,44 B
Long-Term Debt
Earnings Per Share
¥0,00
Revenue Per Share
¥1,76
Gross Margin %
73,76%
Market Cap
¥19,29 B
Long-Term Debt
¥0,44 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
EPS Earnings Per Share ¥0,09 ¥0,26 ¥0,45 ¥0,27 ¥0,64 ¥0,09 ¥0,68 ¥-0,35 ¥0,05 ¥-0,60 ¥0,10 ¥0,03 ¥0,17 ¥0,15 ¥0,14
Earnings Earnings ¥143,94M ¥415,83M ¥720,56M ¥432,36M ¥989,59M ¥138,37M ¥1,05B ¥-538,10M ¥76,87M ¥-842,40M ¥140,40M ¥42,12M ¥241,64M ¥210,60M ¥196,56M
RPS Revenue Per Share ¥1,76 ¥2,18 ¥3,18 ¥2,16 ¥1,90 ¥0,73 ¥0,57 ¥0,43 ¥0,38 ¥0,72 ¥0,51 ¥0,00 ¥0,38 ¥0,34 ¥0,26
Revenue Revenue ¥2,82B ¥3,48B ¥5,09B ¥3,46B ¥2,94B ¥1,12B ¥879,04M ¥668,26M ¥591,00M ¥1,01B ¥719,02M ¥0,00M ¥537,56M ¥473,81M ¥358,79M
OCF Operating Cash Flow ¥1,04B ¥1,13B ¥0,00M ¥705,28M ¥114,19M ¥62,02M ¥0,00M ¥-57,04M ¥-89,94M ¥-69,41M ¥-65,93M ¥0,00M ¥78,38M ¥91,98M ¥86,71M
FCF Free Cash Flow ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥-289,61M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥-277,45M ¥0,00M ¥0,00M
OM Operating Margin 0,85% 17,86% 22,75% 22,88% 34,84% 15,29% 14,43% -13,92% -19,36% -23,33% -37,12% 8,53% 41,43% 41,75% 49,39%
GM % Gross Margin % 73,76% 81,75% 86,81% 88,35% 86,24% 79,02% 79,11% 67,08% 46,07% 39,66% 41,59% 70,91% 86,45% 89,28% 88,89%
FCFS Free Cash Flow Per Share ¥0,30 ¥0,12 ¥0,07 ¥-0,25 ¥-0,19 ¥-0,19 ¥-0,19 ¥-0,22 ¥-0,24 ¥-0,24 ¥-0,21 ¥-0,36 ¥-0,20 ¥-0,08 ¥-0,07
LT Debt Long-Term Debt ¥433,34M ¥434,90M ¥314,24M N/A N/A N/A N/A N/A ¥100,00M ¥595,35M ¥990,76M ¥988,10M N/A N/A ¥78,28M
Sha. Stocks 1.599,35M 1.599,35M 1.601,24M 1.601,34M 1.546,24M 1.537,44M 1.537,44M 1.537,44M 1.537,44M 1.404M 1.404M 1.404M 1.421,41M 1.404M 1.404M
×